Status:
COMPLETED
Use of Behavioral Economics in Repeat SARS-CoV-2 (COVID-19) Antibody Testing in Disadvantaged Communities
Lead Sponsor:
University of Southern California
Collaborating Sponsors:
AltaMed Health Services Corporation
National Institute on Aging (NIA)
Conditions:
SARS-CoV-2
Eligibility:
All Genders
5+ years
Phase:
NA
Brief Summary
Repeat testing for SARS-CoV-2 antibodies in disadvantaged communities will help identify active and recovered infections over time, and as more is understood about antibody protection, it may help ide...
Detailed Description
The rapid spread of the SARS-CoV-2 virus has greatly impacted underserved populations. This project aims to understand social and behavioral determinants of COVID-19 testing and variations within sub-...
Eligibility Criteria
Inclusion
- Adults and children 5 years of age and older
Exclusion
- Children under 5 years of age
Key Trial Info
Start Date :
June 29 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 3 2023
Estimated Enrollment :
2164 Patients enrolled
Trial Details
Trial ID
NCT04901624
Start Date
June 29 2021
End Date
June 3 2023
Last Update
August 14 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
AltaMed Health
Los Angeles, California, United States, 90022